Alosenn


Combined with:

Aspirin
Lasix
Loxonin
Mucosta
Norvasc
Pursennid

Indications and Reactions:

Role Indications Reactions
Secondary
Constipation 19.3%
Hyperphosphataemia 17.6%
Drug Use For Unknown Indication 7.5%
Hypertension 7.5%
Dermatitis Allergic 6.4%
Hypercholesterolaemia 6.4%
Product Used For Unknown Indication 4.3%
Renal Transplant 4.3%
Drug Exposure During Pregnancy 3.7%
Diabetes Mellitus 2.7%
Hyperlipidaemia 2.7%
Insomnia 2.7%
Breast Cancer Metastatic 2.1%
Hyperkalaemia 2.1%
Reflux Oesophagitis 2.1%
Rheumatoid Arthritis 2.1%
Cervix Carcinoma Recurrent 1.6%
Depression 1.6%
Diabetic Neuropathy 1.6%
Sciatica 1.6%
Thrombocytopenic Purpura 13.5%
Abdominal Pain Upper 10.8%
Shock 8.1%
Toxic Epidermal Necrolysis 8.1%
White Blood Cell Count Decreased 8.1%
Death 5.4%
Large Intestine Perforation 5.4%
Renal Tubular Disorder 5.4%
Volvulus 5.4%
Blood Uric Acid Increased 2.7%
Constipation 2.7%
Drug Withdrawal Syndrome Neonatal 2.7%
Gastric Ulcer 2.7%
Liver Disorder 2.7%
Nail Disorder 2.7%
Neck Pain 2.7%
Pseudo-bartter Syndrome 2.7%
Quadriplegia 2.7%
Thrombocytopenia 2.7%
Toxic Skin Eruption 2.7%
Concomitant
Constipation 18.6%
Hypertension 13.3%
Drug Use For Unknown Indication 9.8%
Rheumatoid Arthritis 7.8%
Prophylaxis 7.0%
Insomnia 6.5%
Product Used For Unknown Indication 6.0%
Diabetes Mellitus 4.4%
Pain 3.5%
Gastritis 3.5%
Renal Transplant 2.4%
Parkinson's Disease 2.4%
Depression 2.2%
Schizophrenia 2.2%
Angina Pectoris 2.0%
Hyperlipidaemia 1.9%
Rash 1.8%
Herpes Zoster 1.7%
Gastric Ulcer 1.5%
Atrial Fibrillation 1.5%
White Blood Cell Count Decreased 13.0%
Vomiting 8.5%
Pyrexia 7.8%
Interstitial Lung Disease 7.5%
Pneumonia 6.3%
Renal Impairment 5.5%
Hepatic Function Abnormal 5.3%
White Blood Cell Count Increased 4.8%
Rhabdomyolysis 4.5%
Sepsis 4.5%
Tremor 4.5%
Urinary Tract Infection 4.3%
Liver Disorder 3.5%
Platelet Count Decreased 3.0%
Renal Disorder 3.0%
Thrombocytopenia 3.0%
Death 2.8%
Gastric Cancer 2.8%
Hypoglycaemia 2.8%
Muscular Weakness 2.8%

Drug Data